Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors

Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors

US Patent 11608343 · Granted Mar 21, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Heterocyclic compounds capable of activating STING2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer2024
Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors2022
[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors2022
[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022